Shimon Slavin Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
JSPR | B | Jasper Therapeutics, Inc | 1.87 | |
ALVR | D | AlloVir, Inc. | -0.87 | |
BRTX | F | BioRestorative Therapies, Inc. | -0.91 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IWC | B | iShares Microcap ETF | 0.07 | |
BTEC | D | Principal Healthcare Innovators Index ETF | 0.02 | |
UWM | B | ProShares Ultra Russell2000 | 0.0 | |
RYLD | B | Global X Russell 2000 Covered Call ETF | 0.0 | |
VTI | A | Vanguard Total Stock Market ETF | 0.0 |
Compare ETFs
- Shimon Slavin
Shimon Slavin, M.D., is an Israeli professor of medicine. Slavin pioneered the use of immunotherapy mediated by allogeneic donor lymphocytes and innovative methods for stem cell transplantation for the cure of hematological malignancies and solid tumors, and using hematopoietic stem cells for induction of transplantation tolerance to bone marrow and donor allografts.
More recently, he's been working on the use of multi-potent mesenchymal stem cells (MSCs) in regenerative medicine for the treatment of neurological, systemic and orthopedic disorders.
He is currently serving as the medical and scientific director of Biotherapy International Center for Innovative Cancer Immunotherapy & Cellular Medicine in Tel Aviv, Israel and as the medical director at Superinfection, a biotechnology company in Budapest, Hungary.
Recent Comments
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
- TraderMike on Trades of the Week: Feb 12 - Feb 16, 2024
- Cos3 on Trades of the Week: Feb 12 - Feb 16, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
From the Blog
Featured Articles